Sam­sung's bi­o­log­ics plant in South Ko­rea re­ceives Form 483 over da­ta in­tegri­ty, oth­er ob­ser­va­tions

FDA in­spec­tors un­cov­ered da­ta in­tegri­ty con­cerns with Sam­sung’s bi­o­log­ics plant, ac­cord­ing to a Form 483 re­leased this week fol­low­ing a 10-day agency in­spec­tion of the South Ko­rea-based site in Au­gust and Sep­tem­ber.

The Form 483 says that the site’s Man­u­fac­tur­ing Sci­en­tif­ic An­a­lyt­i­cal Tech­nol­o­gy (MSAT) lab­o­ra­to­ry (fea­tured here on Sam­sung’s web­site) had “in­ad­e­quate con­trols” over da­ta in­tegri­ty since 2013.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER